The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of IBI110 in combination with sintilimab in first-line advanced HER2-negative gastric cancer or gastroesophageal junction cancer: Updated results from a phase Ib study.
 
Chenyu Mao
No Relationships to Disclose
 
Jiong Qian
No Relationships to Disclose
 
Yuan Gao
No Relationships to Disclose
 
Ying Liu
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Jiuwei Cui
No Relationships to Disclose
 
Yuling Chen
Employment - Innovent Biologics
 
Haonan Chen
Employment - Innovent Biologics
 
Li Zhao
Employment - Innovent Biologics
 
Hongli Wang
Employment - Innovent Biologics
 
Nong Xu
No Relationships to Disclose